The Tata Trust and The Global Fund backed Indian Health Fund (IHF) Monday announced that it had chosen four innovators, three related to tuberculosis and one to malaria in its goal of supporting national efforts to effectively tackle eradicate these diseases.
The aim for selecting these innovators aims at leveraging technology for improving early detection and prompt treatment along with promoting diagnostics feasible for primary health care facilities.
It also aims to support national efforts to effectively tackle eradicate these diseases which is crucial health challenges in India.
The government has set a target of eliminating TB by 2025 and malaria by 2030. India contributes to 27% of the global TB burden and 68% of all malaria cases in the Southeast Asia region
IHF was launched in 2016 by Tata Trusts in collaboration with The Global Fund, to drive innovations towards key infectious disease challenges in India.
It supports individuals and organizations with already germinated innovative strategies, services, products, such that they become sustainable and scalable solutions in addressing TB and malaria.
The initiative is a long-term exercise aligned with country’s goal of eliminating TB by 2025 and malaria by 2030. It will promote innovative solutions such that they are widely accessible and are affordable.